5.25

0.57% 0.03

Puma Biotechnology Inc (PBYI)

Overview News Price History Option Chain Financials Discussions Forecast

Puma Biotechnology Inc stock is traded at $5.25, with a volume of 669.77K. It is up +0.57% in the last 24 hours and up +51.30% over the past month. Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Previous Close:

$5.22

Open:

$5.23

24h Volume:

669.77K

Relative Volume:

1.33

Market Cap:

$264.45M

Revenue:

$230.47M

Net Income/Loss:

$30.28M

P/E Ratio:

8.6066

EPS:

0.61

Net Cash Flow:

$38.86M

1W Performance:

-8.38%

1M Performance:

+51.30%

6M Performance:

+80.72%

1Y Performance:

+115.16%

1-Day Range:

$5.04

$5.37

1-Week Range:

$4.81

$6.07

52-Week Range:

$2.225

$6.07

Puma Biotechnology Inc Stock (PBYI) Company Profile

Name

Puma Biotechnology Inc

Sector

Healthcare (1157)

Industry

Biotechnology (645)

Phone

(424) 248-6500

Address

10880 WILSHIRE BLVD., LOS ANGELES, CA

Employee

172

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

PBYI's Discussions on Twitter

Compare PBYI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PBYI Puma Biotechnology Inc	5.25	252.11M	230.47M	30.28M	38.86M	0.61
VRTX Vertex Pharmaceuticals Inc	395.12	99.96B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	589.48	60.83B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	454.38	59.89B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	660.00	40.47B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	313.67	37.96B	3.81B	-644.79M	-669.77M	-6.24

Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-28-21	Upgrade	Citigroup	Neutral → Buy
Jun-25-20	Resumed	BofA/Merrill	Underperform
Oct-08-19	Downgrade	Goldman	Neutral → Sell
May-10-19	Downgrade	Cantor Fitzgerald	Overweight → Neutral
May-10-19	Downgrade	Citigroup	Buy → Neutral
Jan-17-19	Initiated	Leerink Partners	Mkt Perform
Jan-03-19	Downgrade	Guggenheim	Buy → Neutral
Nov-19-18	Upgrade	Goldman	Sell → Neutral
Nov-02-18	Downgrade	BofA/Merrill	Buy → Underperform
Nov-02-18	Downgrade	JP Morgan	Neutral → Underweight
Oct-01-18	Initiated	Cantor Fitzgerald	Overweight
Sep-17-18	Initiated	Goldman	Sell
May-11-18	Reiterated	Stifel	Buy
Nov-10-17	Reiterated	Citigroup	Buy
Nov-10-17	Reiterated	RBC Capital Mkts	Sector Perform
Oct-02-17	Reiterated	Stifel	Buy
Sep-11-17	Reiterated	Credit Suisse	Outperform
Jul-10-17	Resumed	Leerink Partners	Outperform
Jun-06-17	Reiterated	RBC Capital Mkts	Sector Perform
May-25-17	Reiterated	RBC Capital Mkts	Sector Perform
Mar-02-17	Reiterated	RBC Capital Mkts	Sector Perform

View All

Puma Biotechnology Inc Stock (PBYI) Latest News

Aug 19, 2025

Puma Biotechnology Inc. Shows Support at Fibonacci LevelForecast Cut & Comprehensive Market Scan Reports - 선데이타임즈

Aug 19, 2025

Aug 18, 2025

Published on: 2025-08-19 05:35:25 - newsyoung.net

Aug 18, 2025

Live Chart Scan Detects Wedge Pattern in Puma Biotechnology Inc.Market Activity Summary & AI Forecast Swing Trade Picks - sundaytimes.kr

Aug 18, 2025

Puma Biotechnology (PBYI.O) Under Pressure: Technical Clues and Market Sentiment Point to Liquidity-Driven Decline - AInvest

Aug 18, 2025

Puma Biotechnology shares rise 2.08% premarket after Case IH unveils its highest horsepower tractor. - AInvest

Aug 18, 2025

Aug 17, 2025

What is Puma Biotechnology Inc. s revenue forecastJuly 2025 Breakouts & Weekly Top Performers Watchlists - classian.co.kr

Aug 17, 2025

Aug 16, 2025

Published on: 2025-08-16 21:30:39 - metal.it

Aug 16, 2025

Barclays Maintains a Sell Rating on Puma Biotechnology (PBYI) With a $2 PT - MSN

Aug 16, 2025

Aug 15, 2025

How to build a dashboard for Puma Biotechnology Inc. stockJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - Newser

Aug 15, 2025

Is a relief rally coming for Puma Biotechnology Inc. holders2025 Price Targets & Free Verified High Yield Trade Plans - Newser

Aug 15, 2025

Puma Biotechnology shares rise 8.84% intraday after JD Sports Fashion mentions PUMA in retro football shirts article. - AInvest

Aug 15, 2025

Additional Considerations Required While Assessing Puma Biotechnology's (NASDAQ:PBYI) Strong Earnings - Yahoo Finance

Aug 15, 2025

How to forecast Puma Biotechnology Inc. trends using time seriesAnalyst Downgrade & Safe Entry Zone Identification - Newser

Aug 15, 2025

Why is Puma Biotechnology Inc. stock going downWeekly Market Summary & Risk Controlled Stock Alerts - mustnews.co.kr

Aug 15, 2025

Aug 14, 2025

Published on: 2025-08-15 07:16:55 - sundaytimes.kr

Aug 14, 2025

Puma Biotechnology Inc. Matches Institutional Buying FilterAnalyst Upgrade & Weekly Watchlist for Consistent Profits - beatles.ru

Aug 14, 2025

Aug 13, 2025

Can trapped investors hope for a rebound in Puma Biotechnology Inc.2025 Stock Rankings & AI Enhanced Execution Alerts - Newser

Aug 13, 2025

Using AI based signals to follow Puma Biotechnology Inc.July 2025 Reactions & Accurate Buy Signal Alerts - Newser

Aug 13, 2025

Aug 12, 2025

Puma Biotechnology Reports Strong Q2 2025 Earnings - TipRanks

Aug 12, 2025

Volatility clustering patterns for Puma Biotechnology Inc.Chart Driven Opportunity Scanner with Alerts - Newser

Aug 12, 2025

Should Value Investors Buy Puma Biotechnology (PBYI) Stock? - Yahoo Finance

Aug 12, 2025